期刊
NATURE NEUROSCIENCE
卷 10, 期 1, 页码 93-99出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nn1812
关键词
-
资金
- NIDA NIH HHS [F32 DA019727, K08 DA000302-05] Funding Source: Medline
- NATIONAL INSTITUTE ON DRUG ABUSE [F32DA019727, K08DA000302] Funding Source: NIH RePORTER
Chronic morphine administration ( via subcutaneous pellet) decreases the size of dopamine neurons in the ventral tegmental area (VTA), a key reward region in the brain, yet the molecular basis and functional consequences of this effect are unknown. In this study, we used viral-mediated gene transfer in rat to show that chronic morphine-induced downregulation of the insulin receptor substrate 2 (IRS2)-thymoma viral proto-oncogene (Akt) signaling pathway in the VTA mediates the decrease in dopamine cell size seen after morphine exposure and that this downregulation diminishes morphine reward, as measured by conditioned place preference. We further show that the reduction in size of VTA dopamine neurons persists up to 2 weeks after morphine withdrawal, which parallels the tolerance to morphine's rewarding effects caused by previous chronic morphine exposure. These findings directly implicate the IRS2-Akt signaling pathway as a critical regulator of dopamine cell morphology and opiate reward.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据